Dextroamphetamine as an Adjunct in Cocaine Treatment - 1

National Institute on Drug Abuse (NIDA)120 enrolled

Overview

The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

120

Conditions

Interventions

DextroamphetamineDRUG

15 mg for first 8 weeks and 30 mg for 2nd 8 weeks

D-AmphetamineDRUG

30 mg for the first 8 weeks and 60 for the second 8 weeks (16 weeks total)

PlaceboDRUG

Placebo

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Please contact site for information.

Locations (1)

University of Texas Health Science Center

Houston, Texas, United States

Outcomes

Primary Outcomes

verifiable cocaine abstinence

Time frame: 16 weeks of study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.